Puneet Shroff, MD
Allergy & Immunology · Tucson, AZNPI 1265645782
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,353 of the $3,813 with a category attached, or 61.7%. 19 manufacturers reported payments, led by GSK at 41.9% of the total. Reporting peaked in 2022 at $1,507 and has fallen 70.7% since, to $442 in 2025.
Across 80 payments — averaging $47.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$2K
- AstraZeneca$611
- Amgen$220
- Takeda Pharmaceuticals U.S.A., Inc.$208
- Regeneron Healthcare Solutions, Inc.$167
- Sanofi$164
- plus $845 from 13 others
What the payments were for
- Speaking & faculty fees$1,30034%
- Food & beverage$2,35362%
- Education$1604%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 8 | $1,599 |
| AstraZeneca | 16 | $611 |
| Amgen | 11 | $220 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $208 |
| Regeneron Healthcare Solutions, Inc. | 6 | $167 |
| Sanofi | 5 | $164 |
| Kls-martin L.p. | 1 | $145 |
| Biocryst US Sales Co., LLC | 1 | $125 |
| Shire North American Group Inc | 3 | $124 |
| Novartis | 5 | $92 |
| Grifols USA, LLC | 4 | $71 |
| Stryker | 1 | $59 |
| Genentech, Inc. | 1 | $58 |
| UCB, Inc. | 1 | $51 |
| Regeneron | 1 | $44 |
| CSL Behring | 2 | $29 |
| Bio Products Laboratory USA, Inc. | 2 | $17 |
| LEO Pharma Inc. | 1 | $15 |
| Galderma Laboratories, L.p. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,813 in reported general payments places this provider in the 55th percentile of 90 allergy & immunology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent SyringeDupilumab | 54 | $240,539 |
| Dupixent PenDupilumab | 59 | $217,805 |
| HizentraImmun Glob G(Igg)/Pro/Iga 0-50 | 18 | $143,869 |
| Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov50 | 39 | $119,345 |
| CuvitruImmun Glob G(Igg)/Gly/Iga Ov50 | 24 | $95,318 |
| XolairOmalizumab | 23 | $80,804 |
| PrivigenImmun Glob G(Igg)/Pro/Iga 0-50 | 11 | $59,128 |
| NucalaMepolizumab | 13 | $58,840 |
| Spiriva RespimatTiotropium Bromide | 19 | $11,199 |
| Breo ElliptaFluticasone/Vilanterol | 15 | $11,149 |
| SymbicortBudesonide/Formoterol Fumarate | 37 | $11,079 |
| Advair HfaFluticasone Propion/Salmeterol | 13 | $7,899 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 13 | $6,470 |
| Epinephrine | 25 | $5,661 |
| Azelastine Hcl | 84 | $3,710 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc.Gammagard Liquid, Cuvitru | $208 | $214,66363 claims |
| CSL BehringHizentra, Privigen | $29 | $202,99729 claims |
| Genentech, Inc.Xolair | $58 | $80,80423 claims |
| GSKNucala, Breo Ellipta | $1,599 | $69,98928 claims |
| AstraZenecaSymbicort | $611 | $11,07937 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 90 allergy & immunology providers in Arizona.
Other allergy & immunology in Tucson
- Tara CarrTucson$76K
- Pierre SakaliTucson$25K
- George MakolTucson$13K
- Nicole LahoodTucson$13K
- Nabeeh LahoodTucson$13K
- Martin BartelsTucson$7K
- Kudagal MurthyTucson$3K
- Anjali JainTucson$2K
- Kaitlyn LeaheyTucson$1K
- Michael ManningScottsdale$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.